ARPA-H funds ADVOCATE to build heart care AI that can change meds

In short: A federal health program is funding an AI system for certain heart patients that could recommend care and, in limited cases, change prescriptions under supervision.

What happened

ARPA-H, a U.S. government health research agency, is running a program called ADVOCATE. It is focused on people with heart failure and people recovering after a heart attack.

ARPA-H says the goal is a 24/7 clinical AI system that can connect to patient records and help with everyday care tasks. That includes scheduling, advice on diet and exercise, and support for doctors with diagnosis and treatment choices.

The most sensitive part is medication. ARPA-H says the system is intended, in some cases, to write and modify prescriptions, within a clinical framework. This is not described as an AI that can prescribe any drug for any condition.

ARPA-H also says it is building a separate “overseer” AI to monitor the patient-facing AI after it is deployed. Think of it like having a second set of eyes that keeps checking the first system’s work (like a safety inspector watching a machine on a factory floor).

The program is funded at up to $62.7 million over multiple years, with up to $33.7 million committed in the first year. Separately, Kaiser Permanente received up to $16 million to run a large randomized evaluation of how this kind of “agentic AI” can be used responsibly in heart-failure care. “Agentic AI” means software that can take actions, not just answer questions.

Why it matters

If AI systems start taking clinical actions, even in narrow areas like heart care, patients and families will want clear rules about safety, oversight, and who is accountable when something goes wrong. The available sources also do not show venture capital investors directly controlling the ARPA-H program, but they do point to a broader push to move clinical AI into real care settings.

Source: NYTimes